- Home
- TNGX vs BXC Comparison
TNGX vs BXC Comparison
Compare TNGX & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- BXC
- Stock Information
- Founded
- TNGX 2014
- BXC 2004
- Country
- TNGX United States
- BXC United States
- Employees
- TNGX 140
- BXC 2000
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- BXC Wholesale Distributors
- Sector
- TNGX Health Care
- BXC Consumer Discretionary
- Exchange
- TNGX Nasdaq
- BXC Nasdaq
- Market Cap
- TNGX 747.9M
- BXC 882.1M
- IPO Year
- TNGX N/A
- BXC 2004
- Fundamental
- Price
- TNGX $6.98
- BXC $106.20
- Analyst Decision
- TNGX Strong Buy
- BXC Strong Buy
- Analyst Count
- TNGX 8
- BXC 3
- Target Price
- TNGX $15.14
- BXC $135.67
- AVG Volume (30 Days)
- TNGX 1.3M
- BXC 62.5K
- Earning Date
- TNGX 11-06-2024
- BXC 10-29-2024
- Dividend Yield
- TNGX N/A
- BXC N/A
- EPS Growth
- TNGX N/A
- BXC N/A
- EPS
- TNGX N/A
- BXC 4.31
- Revenue
- TNGX $42,509,000.00
- BXC $3,017,117,000.00
- Revenue This Year
- TNGX $18.15
- BXC N/A
- Revenue Next Year
- TNGX N/A
- BXC $5.75
- P/E Ratio
- TNGX N/A
- BXC $24.00
- Revenue Growth
- TNGX 26.16
- BXC N/A
- 52 Week Low
- TNGX $5.15
- BXC $67.76
- 52 Week High
- TNGX $13.01
- BXC $132.67
- Technical
- Relative Strength Index (RSI)
- TNGX 33.20
- BXC 56.30
- Support Level
- TNGX $6.72
- BXC $101.08
- Resistance Level
- TNGX $7.78
- BXC $108.93
- Average True Range (ATR)
- TNGX 0.56
- BXC 3.39
- MACD
- TNGX -0.11
- BXC -0.01
- Stochastic Oscillator
- TNGX 8.48
- BXC 48.30
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.